tm logo

Monitor this mark

View On USPTO

SIRONAX
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 17 Jul 2024

Last Applicant/ Owned by

Sironax Ltd

P.O. Box 2547

Grand Cayman

KY

KY-1104

Serial Number

97020951 filed on 10th Sep 2021

Registration Number

N/A

Correspondent Address

Kerrijane John

Kerrijane John FISH & RICHARDSON P.C.

MINNEAPOLIS, MN 55440

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SIRONAX

Pharmaceutical preparations and substances for the treatment of neurological diseases and disorders, degenerative diseases and disorders, and inflammatory diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for the treatment of neurological diseases and disorders, degenerative diseases and disorders, and inflammatory diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97020951

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 518290004001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.17.12 -

Infinity symbol

Legal History

Show more

Status DateAction Taken
17th Jul 2024SOU EXTENSION 4 GRANTED
17th Jul 2024SOU EXTENSION 4 FILED
17th Jul 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Jul 2024SOU TEAS EXTENSION RECEIVED
20th Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Feb 2024SOU TEAS EXTENSION RECEIVED
19th Feb 2024SOU EXTENSION 3 GRANTED
19th Feb 2024SOU EXTENSION 3 FILED
17th Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15th Aug 2023SOU EXTENSION 2 GRANTED